Business Wire

CHANDLER, Ariz.--(BUSINESS WIRE)-- Rogers Corporation (NYSE: ROG) announced today that its executive management will participate in the following upcoming investor conferences.

The B. Riley Securities 24th Annual Institutional Investor Conference in Beverly Hills, CA on May 23, 2024. Rogers will participate in a fireside chat beginning at 1:00 pm PDT. A webcast of the event will not be available.

The Stifel 2024 Cross Sector Insight Conference in Boston, MA on... (continue reading...)

TORONTO--(BUSINESS WIRE)-- Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today the results of its Annual and Special Meeting of Shareholders held today, May 14, 2024 (the “Meeting”).

Satellos is pleased to announce that all of the nominees listed in the management... (continue reading...)

Significant managed portfolio expansion continues recent growth trajectory

• Revenue increased 4% to $10.6 million; 15th consecutive period of year-over-year growth
  • 45% increase in recurring fee-based Property & Parking Management revenue
  • 20 additional AUM vs. prior year, including 12 new third-party ParkX contracts
• Net income of $0.9 million, an increase of 21% vs. prior year; Adjusted EBITDA of $1.5 million
• 10 commercial leases executed in Q124,... (continue reading...)

This press release contains forward-looking information that is based upon assumptions and is subject to risks and uncertainties as indicated in the cautionary note contained within this press release. All amounts are in Canadian dollars.

TORONTO--(BUSINESS WIRE)-- Dream Unlimited Corp. (TSX: DRM) (“Dream”, “the Company” or “we”) today announced its financial results for the three months ended March 31, 2024 (“first quarter”).

“As anticipated,... (continue reading...)

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) today announced that several abstracts featuring data from its oncology portfolio will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held May 31 – June 4 in Chicago, and at the European Hematology Association 2024 (EHA2024) Congress held on June 13-16 in Madrid, Spain, and virtually.

"The data being presented at ASCO and EHA demonstrates Incyte’s... (continue reading...)